MycoMedica
MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs, including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and lion's mane), for the prevention and treatment of psychiatric and neurological disorders. It raised $60 million in Series A funding in 2022 and is advancing pre-clinical and clinical research toward FDA approval. MycoMedica is a life-sciences drug-development company and publishes no public developer API, documentation, or developer portal.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
MycoMedica is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — MycoMedica scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Resources
Every other property we hold for MycoMedica — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Company 1
The organization behind the API
MycoMedica is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/mycomedica · machine-readable index on apis.io